LncRNA PCGEM1 Induces Ovarian Carcinoma Tumorigenesis and Progression Through RhoA Pathway | Zendy

Shuo Chen | Zendy; Lili Wang | Zendy; Kaixuan Sun | Zendy; Yao Liu | Zendy; Xue Guan | Zendy; ZhiHong Zong | Zendy; Yang Zhao | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

LncRNA PCGEM1 Induces Ovarian Carcinoma Tumorigenesis and Progression Through RhoA Pathway

Author(s) -

Shuo Chen,

Lili Wang,

Kaixuan Sun,

Yao Liu,

Xue Guan,

ZhiHong Zong,

Yang Zhao

Publication year - 2018

Publication title -

cellular physiology and biochemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.486

H-Index - 87

eISSN - 1421-9778

pISSN - 1015-8987

DOI - 10.1159/000490931

Subject(s) - rhoa , cancer research , carcinogenesis , downregulation and upregulation , mmp2 , ovarian cancer , gene silencing , cell growth , biology , cancer , chemistry , medicine , microbiology and biotechnology , signal transduction , gene , biochemistry , genetics

Prostate cancer gene expression marker 1 (PCGEM1) is a long noncoding RNA (lncRNA) and is well known as a promoter in prostate cancer and osteoarthritis synoviocytes. However, the role PCGEM1 plays in epithelial ovarian cancer is unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research